Syncona Limited NPV (SYNC) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Jan 2020 08:45 AM
RNS
Notice of Capital Markets Day
19 Dec 2019 07:00 AM
RNS
Syncona makes further $80m commitment to Freeline
09 Dec 2019 07:00 AM
RNS
Autolus announces new data in AUTO3 at ASH
09 Dec 2019 07:00 AM
RNS
Autolus announces new data at ASH Annual Meeting
21 Nov 2019 07:00 AM
RNS
Syncona leads £32 million financing in Azeria
21 Nov 2019 07:00 AM
RNS
Interim Results
11 Nov 2019 09:00 AM
RNS
Notice of Results
07 Nov 2019 12:32 PM
RNS
Autolus reports Q3 2019 Financial Results
06 Nov 2019 02:20 PM
RNS
Autolus to Present New Data at the ASH Meeting
06 Nov 2019 02:13 PM
RNS
Freeline presents pre-clinical data at ASH meeting
03 Sep 2019 07:00 AM
RNS
Syncona cornerstones £100m financing in Achilles
03 Sep 2019 07:00 AM
RNS
Syncona makes £48 million commitment to Gyroscope
12 Aug 2019 07:00 AM
RNS
Quarterly Update
08 Aug 2019 12:59 PM
RNS
Autolus reports Q2 2019 Financial Results
01 Aug 2019 07:00 AM
RNS
Completion of sale of Blue Earth Diagnostics
31 Jul 2019 12:24 PM
RNS
Total Voting Rights
30 Jul 2019 11:55 AM
RNS
Result of AGM
18 Jul 2019 03:51 PM
RNS
Issue of shares per 2019 dividend & PDMR dealings
11 Jul 2019 11:21 AM
RNS
Issue of shares pursuant to LTIP and PDMR dealings
08 Jul 2019 07:00 AM
RNS
Freeline provides 12 month Haemophilia B data
28 Jun 2019 12:33 PM
RNS
2019 Dividend Scrip Reference Price
27 Jun 2019 11:44 AM
RNS
Publication of Annual Report and Notice of AGM
27 Jun 2019 07:00 AM
RNS
Sale of Blue Earth Diagnostics to Bracco Imaging
21 Jun 2019 04:18 PM
RNS
Director Information
13 Jun 2019 02:27 PM
RNS
Dividend Announcement
13 Jun 2019 07:00 AM
RNS
Annual Financial Report
04 Jun 2019 07:00 AM
RNS
Appointment of Chair-Designate and NED
20 May 2019 07:00 AM
RNS
Syncona founds Quell with £35m Series A Financing
14 May 2019 12:00 PM
RNS
Autolus reports Q1 2019 Financial Results
07 May 2019 07:00 AM
RNS
BED announces initial clinical experience of PSMA
16 Apr 2019 07:00 AM
RNS
Autolus announces closing of public offering
11 Apr 2019 07:09 AM
RNS
Autolus announces pricing of public offering
11 Apr 2019 07:00 AM
RNS
Creation of leading retinal gene therapy platform
09 Apr 2019 07:00 AM
RNS
Autolus announces launch of proposed offering
01 Apr 2019 06:14 PM
RNS
Autolus presents initial AUTO1 adult ALL data
27 Mar 2019 11:12 AM
RNS
Director/PDMR Shareholding
26 Mar 2019 10:18 AM
RNS
Autolus hosts R&D day and updates on AUTO3
20 Mar 2019 04:27 PM
RNS
Director/PDMRs Shareholding
19 Mar 2019 05:48 PM
RNS
Standard form for notification of major holdings
19 Mar 2019 04:44 PM
RNS
Directors/PDMR Shareholdings
18 Mar 2019 04:15 PM
RNS
Notification of Major Holdings
12 Mar 2019 07:00 AM
RNS
Update on management of strategic capital pool
04 Mar 2019 07:11 AM
RNS
Nightstar agreement to be acquired by Biogen
26 Feb 2019 07:00 AM
RNS
Syncona leads CHF 35 million financing in Anaveon
19 Feb 2019 11:52 AM
RNS
Autolus announces Results from CARPALL Trial
13 Feb 2019 07:00 AM
RNS
Quarterly Update
16 Jan 2019 07:00 AM
RNS
Appointment of Joint Corporate Broker
17 Dec 2018 12:38 PM
RNS
Change of Registered Office - Released in Error
17 Dec 2018 11:47 AM
RNS
Change of Registered Office
04 Dec 2018 07:00 AM
RNS
Freeline presents data at the ASH Annual Meeting

Syncona Limited is a Guernsey-based investment company focusing on long-term capital appreciation through investments in life science businesses and single or multi-asset projects. The company aims to build a diversified portfolio of global healthcare companies, with a focus on developing treatments for patients by partnering with academic founders and management teams. Syncona's investment objective is to achieve superior long-term capital appreciation.

Syncona share price launched at 104p in 2012.

UK 100

Latest directors dealings